Blackstone Inc (NYSE:BX) is one of the best NYSE stocks to buy for the long term. Blackstone Inc (NYSE:BX) led a $10 billion debt investment in the Australian AI infrastructure company Firmus, Reuters reported on February 9.
Pixabay/Public Domain
Confirming the deal, Firmus said in a press release on February 9 that it would use the financing to bankroll the next phase of its Project Southgate to meet the increasing demand for high-performance computing. The Firmus’ Project Southgate is a national rollout of an AI Factory platform.
In other news, Chinese regulators have given their approval to Blackstone’s deal to acquire Hologic (HOLX), Reuters reported on February 10. Blackstone teamed up with TPG (TPG) to acquire Hologic, a specialist in women’s health diagnosis.
On February 2, Piper Sandler strategists reiterated a Neutral rating on BX stock but slashed the price target from $168 to $158. In taking this action, the strategists pointed to Blackstone’s 2026 guidance, which they view as tepid relative to market expectations. Consequently, the strategies lowered their 2026 and 2027 EPS estimates for Blackstone.
Blackstone Inc (NYSE:BX) is an alternative investment management company. It serves institutional and individual investors. With more than $1 trillion of assets under management, Blackstone is the world’s largest alternative asset manager.
While we acknowledge the potential of BX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Best Medical Technology Stocks to Invest In and 12 Best Foreign Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
